Selank 5mg

Selank is derived from the tetrapeptide tuftsin (Thr-Lys-Pro-Arg), incorporating a Pro-Gly-Pro extension at the C-terminus to form the heptapeptide TKPRPGP. This structural modification influences peptide stability characteristics and resistance to enzymatic degradation relative to the parent peptide.

The extension also alters the physicochemical and pharmacological properties of the molecule, making Selank a useful research tool for studies of peptide engineering, structure-function relationships, and peptide-mediated signaling systems.

Selank is a synthetic peptide with a distinct structural and pharmacological profile compared to classical small-molecule compounds. Experimental investigations have examined its interactions with peptide-mediated signaling pathways, GABAergic-associated regulatory systems, receptor-ligand interactions, and molecular communication networks.

These characteristics make Selank valuable for studies investigating peptide-based signaling mechanisms, signal transduction processes, and receptor-associated regulatory pathways.

Consistent with its tuftsin-derived sequence, Selank has been investigated in relation to peptide-associated regulatory pathways, molecular signaling networks, and receptor-mediated communication systems. Experimental studies have examined interactions with transcriptional control mechanisms, signaling cascades, and peptide-dependent regulatory processes.

These properties have established Selank as a useful research tool for investigations of peptide pharmacology, signal transduction, molecular regulation, and mechanistic evaluation of peptide-mediated biological systems.